GlassScriptPhysician profile
Lindsay G Spring
NPI 1831490440
$1,016.35
in general payments reported to CMS, 2019-2025
15 companies · $18.88 in 2025
The $18.88 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $514 · 2023: $276 · 2024: $54.27 · 2025: $18.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $235.02 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $172.59 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $105.78 | 2023 | Myfembree |
| Organon LLC | $89.08 | 2021-2023 | Nexplanon |
| Abbvie INC. | $68.59 | 2021-2022 | |
| Astellas Pharma US INC | $54.27 | 2024 | Veozah |
| Avion Pharmaceuticals | $51.27 | 2022-2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $48.81 | 2021 | |
| Exeltis, USA INC. | $47.80 | 2022-2023 | Slynd |
| Hologic Sales and Service, LLC | $40.07 | 2022-2023 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Therapeuticsmd, INC. | $25.47 | 2021-2022 | |
| Daiichi Sankyo INC. | $20.44 | 2022 | |
| Shield Therapeutics INC | $20.23 | 2022 | |
| Ferring Pharmaceuticals INC. | $18.88 | 2025 | Euflexxa |
| Agile Therapeutics, INC. | $18.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Spring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.